View Item 

Show simple item record

Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma

dc.contributor.authorShors, A. R.en_US
dc.contributor.authorKim, S.en_US
dc.contributor.authorWhite, E.en_US
dc.contributor.authorArgenyi, Z.en_US
dc.contributor.authorBarnhill, R. L.en_US
dc.contributor.authorDuray, P.en_US
dc.contributor.authorErickson, L.en_US
dc.contributor.authorGuitart, Joanen_US
dc.contributor.authorHorenstein, M. G.en_US
dc.contributor.authorLowe, Lorien_US
dc.contributor.authorMessina, Julia A.en_US
dc.contributor.authorRabkin, M. S.en_US
dc.contributor.authorSchmidt, B.en_US
dc.contributor.authorShea, C. R.en_US
dc.contributor.authorTrotter, M. J.en_US
dc.contributor.authorPiepkorn, M. W.en_US
dc.date.accessioned2010-06-01T21:58:05Z
dc.date.available2010-06-01T21:58:05Z
dc.date.issued2006-11en_US
dc.identifier.citationShors, A.R.; Kim, S.; White, E.; Argenyi, Z.; Barnhill, R.L.; Duray, P.; Erickson, L.; Guitart, J.; Horenstein, M.G.; Lowe, L.; Messina, J.; Rabkin, M.S.; Schmidt, B.; Shea, C.R.; Trotter, M.J.; Piepkorn, M.W. (2006). "Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma." British Journal of Dermatology 155(5): 988-993. <http://hdl.handle.net/2027.42/74999>en_US
dc.identifier.issn0007-0963en_US
dc.identifier.issn1365-2133en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/74999
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17034530&dopt=citationen_US
dc.format.extent86294 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights2006 The Authors Journal Compilation 2006 British Association of Dermatologistsen_US
dc.subject.otherAtypical Naevien_US
dc.subject.otherCase–Controlen_US
dc.subject.otherDysplastic Naevien_US
dc.subject.otherMelanomaen_US
dc.titleDysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanomaen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelDermatologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationum†† Department of Pathology, University of Michigan, Ann Arbor, MI, U.S.A.en_US
dc.contributor.affiliationother* Cancer Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, U.S.A.en_US
dc.contributor.affiliationother† Departments of Dermatology and Pathology, University of Miami, Miami, FL, U.S.A.en_US
dc.contributor.affiliationother† Department of Pathology, West Roxbury Veterans Affairs Medical Center, West Roxbury, MA, U.S.A.en_US
dc.contributor.affiliationother§ Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN, U.S.A.en_US
dc.contributor.affiliationother¶ Department of Dermatology, Northwestern University, Chicago, IL, U.S.A.en_US
dc.contributor.affiliationother** Dermatopathology, The Dermatology Group, Verona, NJ, U.S.A.en_US
dc.contributor.affiliationother†† Department of Pathology and Medicine, University of South Florida College of Medicine, Tampa, FL, U.S.A.en_US
dc.contributor.affiliationother§§ Rabkin Dermatopathology Laboratory, P.C., Pittsburgh, PA, U.S.A.en_US
dc.contributor.affiliationother¶¶ Departments of Dermatology and Pathology, Children's Hospital, Harvard University Medical Center, Boston, MA, U.S.A.en_US
dc.contributor.affiliationother*** Department of Medicine, University of Chicago, Chicago, IL, U.S.A.en_US
dc.contributor.affiliationother††† Calgary Laboratory Services, Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, Canadaen_US
dc.identifier.pmid17034530en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/74999/1/j.1365-2133.2006.07466.x.pdf
dc.identifier.doi10.1111/j.1365-2133.2006.07466.xen_US
dc.identifier.sourceBritish Journal of Dermatologyen_US
dc.identifier.citedreferenceTripp JM, Kopf AW, Marghoob AA, Bart RS. Management of dysplastic nevi: a survey of fellows of the American Academy of Dermatology. J Am Acad Dermatol 2002; 46: 674 – 82.en_US
dc.identifier.citedreferenceAckerman AB. What naevus is dysplastic, a syndrome and the commonest precursor of malignant melanoma? A riddle and an answer. Histopathology 1988; 13: 241 – 56.en_US
dc.identifier.citedreferenceRoush GC, Nordlund JJ, Forget B et al. Independence of dysplastic nevi from total nevi in determining risk for nonfamilial melanoma. Prev Med 1988; 17: 273 – 9.en_US
dc.identifier.citedreferenceTucker MA, Halpern A, Holly EA et al. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA 1997; 277: 1439 – 44.en_US
dc.identifier.citedreferenceHolly EA, Kelly JW, Shpall SN, Chiu SH. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987; 17: 459 – 68.en_US
dc.identifier.citedreferenceHalpern AC, Guerry D IV, Elder DE et al. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case–control study. Arch Dermatol 1991; 127: 995 – 9.en_US
dc.identifier.citedreferenceGarbe C, Buttner P, Weiss J et al. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case–control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 1994; 102: 695 – 9.en_US
dc.identifier.citedreferenceBataille V, Bishop JA, Sasieni P et al. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer 1996; 73: 1605 – 11.en_US
dc.identifier.citedreferenceAnnessi G, Cattaruzza MS, Abeni D et al. Correlation between clinical atypia and histologic dysplasia in acquired melanocytic nevi. J Am Acad Dermatol 2001; 45: 77 – 85.en_US
dc.identifier.citedreferenceNIH Consensus conference. Diagnosis and treatment of early melanoma. JAMA 1992; 268: 1314 – 19.en_US
dc.identifier.citedreferenceElder DE, Green MH, Guerry D IV et al. The dysplastic nevus syndrome: our definition. Am J Dermatopathol 1982; 4: 455 – 60.en_US
dc.identifier.citedreferencePiepkorn MW, Barnhill RL, Cannon-Albright LA et al. A multiobserver, population-based analysis of histologic dysplasia in melanocytic nevi. J Am Acad Dermatol 1994; 30: 707 – 14.en_US
dc.identifier.citedreferenceGrob JJ, Gouvernet J, Aymar D et al. Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer 1990; 66: 387 – 95.en_US
dc.identifier.citedreferenceRoush GC, Barnhill R. Correlation of clinical pigmentary characteristics with histopathologically-confirmed dysplastic nevi in nonfamilial melanoma patients. Studies of melanocytic nevi IX. Br J Cancer 1991; 64: 943 – 7.en_US
dc.identifier.citedreferenceAhmed I, Piepkorn MW, Rabkin MS et al. Histopathologic characteristics of dysplastic nevi. Limited association of conventional histologic criteria with melanoma risk group. J Am Acad Dermatol 1990; 22: 727 – 33.en_US
dc.identifier.citedreferenceBarnhill RL. Malignant melanoma, dysplastic melanocytic nevi, and Spitz tumors. Histologic classification and characteristics. Clin Plast Surg 2000; 27: 331 – 60, viii.en_US
dc.identifier.citedreferenceCohen J. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 1968; 70: 213 – 20.en_US
dc.identifier.citedreferenceArumi-Uria M, McNutt NS, Finnerty B. Grading of atypia in nevi: correlation with melanoma risk. Mod Pathol 2003; 16: 764 – 71.en_US
dc.identifier.citedreferenceBlack WC, Hunt WC. Histologic correlations with the clinical diagnosis of dysplastic nevus. Am J Surg Pathol 1990; 14: 44 – 52.en_US
dc.identifier.citedreferenceBergman W, Ruiter DJ, Scheffer E, van Volten WA. Melanocytic atypia in dysplastic nevi. Immunohistochemical and cytophotometrical analysis. Cancer 1988; 61: 1660 – 6.en_US
dc.identifier.citedreferenceKlein LJ, Barr RJ. Histologic atypia in clinically benign nevi. A prospective study. J Am Acad Dermatol 1990; 22: 275 – 82.en_US
dc.identifier.citedreferenceSchmidt B, Weinberg DS, Hollister K, Barnhill RL. Analysis of melanocytic lesions by DNA image cytometry. Cancer 1994; 73: 2971 – 7.en_US
dc.identifier.citedreferencePiepkorn M, Meyer LJ, Goldgar D et al. The dysplastic melanocytic nevus: a prevalent lesion that correlates poorly with clinical phenotype. J Am Acad Dermatol 1989; 20: 407 – 15.en_US
dc.identifier.citedreferenceDuncan LM, Berwick M, Bruijn JA et al. Histopathologic recognition and grading of dysplastic melanocytic nevi: an interobserver agreement study. J Invest Dermatol 1993; 100: S318 – 21.en_US
dc.identifier.citedreferenceClemente C, Cochran AJ, Elder DE et al. Histopathologic diagnosis of dysplastic nevi: concordance among pathologists convened by the World Health Organization Melanoma Programme. Hum Pathol 1991; 22: 313 – 19.en_US
dc.identifier.citedreferencede Wit PE, van't Hof-Grootenboer B, Ruiter DJ et al. Validity of the histopathological criteria used for diagnosing dysplastic naevi. An interobserver study by the pathology subgroup of the EORTC Malignant Melanoma Cooperative Group. Eur J Cancer 1993; 29A: 831 – 9.en_US
dc.identifier.citedreferenceWeinstock MA, Barnhill RL, Rhodes AR, Brodsky GL. Reliability of the histopathologic diagnosis of melanocytic dysplasia. The Dysplastic Nevus Panel. Arch Dermatol 1997; 133: 953 – 8.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1365-2133.2006.07466.x.pdf
Size:
84.27KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.